Urea derivatives and their use as tyrosinkinase inhibitors

Details for Australian Patent Application No. 2004266781 (hide)

Owner Merck Patent GmbH

Inventors Soler, Marta; Stahle, Wolfgang; Holzemann, Gunter; Mitjans, Francesc; Adan, Jaume; Jonczyk, Alfred; Crassier, Helene; Ackermann, Karl-August; Rosell-Vives, Elisabet; Rautenberg, Wilfried

Agent Davies Collison Cave

Pub. Number AU-A-2004266781

PCT Pub. Number WO2005/019192

Priority 103 34 663.5 30.07.03 DE

Filing date 2 July 2004

Wipo publication date 3 March 2005

International Classifications

C07D 285/14 (2006.01) Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups

A61K 31/4184 (2006.01)

A61K 31/435 (2006.01) - having six-membered rings with one nitrogen as the only ring hetero atom

A61K 31/4745 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

C07D 209/08 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 213/69 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/70 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/81 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 235/32 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings

C07D 277/64 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 307/86 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 317/64 (2006.01) Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms

C07D 319/18 (2006.01) Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

23 March 2006 PCT application entered the National Phase

  PCT publication WO2005/019192 Priority application(s): WO2005/019192

15 May 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004266783-2-substituted pyrimidines

2004266764-Method for treating aqueous sludge, material so produced and the use thereof